{"id":230146,"date":"2017-07-22T23:03:25","date_gmt":"2017-07-22T21:03:25","guid":{"rendered":"http:\/\/www.pcnen.com\/portal\/?p=230146"},"modified":"2017-07-22T23:03:25","modified_gmt":"2017-07-22T21:03:25","slug":"novi-lijek-protiv-raka-sokirao-naucnike","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2017\/07\/22\/novi-lijek-protiv-raka-sokirao-naucnike\/","title":{"rendered":"Novi lijek protiv raka \u0161okirao nau\u010dnike"},"content":{"rendered":"<p><a href=\"http:\/\/www.pcnen.com\/portal\/wp-content\/uploads\/2012\/08\/Tumor-Marker.jpg\"><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/www.pcnen.com\/portal\/wp-content\/uploads\/2012\/08\/Tumor-Marker.jpg\" alt=\"Tumor-Marker\" width=\"400\" height=\"300\" class=\"aligncenter size-full wp-image-92076\" \/><\/a>Nau\u010dnici su ostali \u0161okirani nakon \u0161to je novi lijek za rak sijedu kosu pacijenata koji su bolovali od raka plu\u0107a obojio u sme\u0111u, pi\u0161e zagreba\u010dki <a href=\"http:\/\/www.jutarnji.hr\/life\/zdravlje\/znanstvenici-sokirani-posljedicom-novog-lijeka-za-karcinom-nekolicini-pacijenata-vratio-je-pigment-u-kosi-vise-nisu-sijedi\/6393392\/\" target=\"_blank\">Jutarnji.<\/a><\/p>\n<p>U 14 slu\u010daja me\u0111u 52, pacijente oboljele od raka plu\u0107a pratili su kako bi vidjeli ho\u0107e li imati lo\u0161ih nuspojava od ljekova Keytruda, Opdivo i Tecentriq.<\/p>\n<p>Kod 13 pacijenata kosa je postala tamnosme\u0111a ili crna, a jednom je potamnjea mjestimi\u010dno, kod svih osim kod jednog pacijenta bolest je stagnirala i reagovali su bolje na tretman od ostalih pacijenata, \u0161to sugeri\u0161e da je tamnjenje kose bila indikacija da lijek djeluje, kazali su nau\u010dnici.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nau\u010dnici su ostali \u0161okirani nakon \u0161to je novi lijek za rak sijedu kosu pacijenata koji su bolovali od raka plu\u0107a obojio u sme\u0111u, pi\u0161e zagreba\u010dki Jutarnji. U 14 slu\u010daja me\u0111u 52, pacijente oboljele od raka plu\u0107a pratili su kako bi vidjeli ho\u0107e li imati lo\u0161ih nuspojava od ljekova Keytruda, Opdivo i Tecentriq. Kod 13 pacijenata [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-230146","post","type-post","status-publish","format-standard","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/230146","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=230146"}],"version-history":[{"count":0,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/230146\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=230146"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=230146"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=230146"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}